Literature DB >> 17618044

Impact of diagnostic delay in testis cancer: results of a large population-based study.

Eric Huyghe1, Audrey Muller, Roger Mieusset, Louis Bujan, Jean-Marc Bachaud, Christine Chevreau, Pierre Plante, Patrick Thonneau.   

Abstract

OBJECTIVE: Testis cancer is the most common cancer in young men, and its incidence continues to rise. Even if prognosis is considered as good, a group with bad prognosis still remains. Diagnostic delay (DD), defined as the time elapsing from the onset of tumour symptoms to the day of diagnosis, is a way to evaluate the rapidity of diagnosis. We assessed the relationship between DD, disease stage, and survival rate.
METHODS: A series of 542 patients diagnosed with a germ cell tumour between 1983 and 2002 at health facilities in the Midi-Pyrenees region, southwest France, were asked about DD. We analysed DD together with data regarding the disease (histologic type, stage), its treatments, and prognosis (impact on survival).
RESULTS: Mean DD was longer in seminoma (4.9+/-6.1 mo) than in non-seminomatous germ cell tumour (NSGCT; 2.8+/-4.0 mo). DD was correlated with disease stage for the whole population (p=0.014) and for NSGCT (p=0.0009), but not for seminoma. DD had a significant impact on the 5-yr survival rate in the overall population (p=0.001) and in the NSGCT group (p=0.001), but not in the seminoma group. Global trends in mean DD did not change over the 20-yr study period, but we observed a slight decrease during the last decade.
CONCLUSIONS: DD is highly correlated with stage and survival in NSGCT. Urologists should promote programmes to enhance awareness and knowledge of testis cancer, so the diagnosis can be made more rapidly.

Entities:  

Mesh:

Year:  2007        PMID: 17618044     DOI: 10.1016/j.eururo.2007.06.003

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  17 in total

Review 1.  Contralateral biopsies in patients with testicular germ cell tumours: What is the rationale?

Authors:  Jan Oldenburg; Klaus-Peter Dieckmann
Journal:  World J Urol       Date:  2016-10-13       Impact factor: 4.226

2.  Testicular Cancer Awareness and Knowledge: Is It the Same? Exploratory Study in a Mixed-Gender Population.

Authors:  Isaac Campos Braga; João Cabral; Nuno Louro; José LaFuente de Carvalho
Journal:  J Cancer Educ       Date:  2017-03       Impact factor: 2.037

3.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

4.  A novel rapid access testicular cancer clinic: prospective evaluation after one year.

Authors:  K Carey; N F Davis; S Elamin; P Ahern; C M Brady; P Sweeney
Journal:  Ir J Med Sci       Date:  2015-03-14       Impact factor: 1.568

Review 5.  Testicular microlithiasis: recent advances in understanding and management.

Authors:  Min-Han Tan; Charis Eng
Journal:  Nat Rev Urol       Date:  2011-03       Impact factor: 14.432

6.  Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options.

Authors:  Michael C Risk; Timothy A Masterson
Journal:  Indian J Urol       Date:  2010 Jan-Mar

7.  Prospectively Identified Incident Testicular Cancer Risk in a Familial Testicular Cancer Cohort.

Authors:  Anand Pathak; Charleen D Adams; Jennifer T Loud; Kathryn Nichols; Douglas R Stewart; Mark H Greene
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-11       Impact factor: 4.254

8.  Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients.

Authors:  Romy Strenziok; Stefan Hinz; Christian Wolf; Tim Conrad; Hans Krause; Kurt Miller; Mark Schrader
Journal:  World J Urol       Date:  2009-06-16       Impact factor: 4.226

Review 9.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

10.  Cannonball Metastatic Lesions in a Young Male: A Case Report.

Authors:  Zubin Arora; Abhijit Duggal
Journal:  World J Oncol       Date:  2014-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.